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Arthritis remains the most common cause of disability in adults in North
America, and is amongst leading conditions causing work limitations. There
is promise in the development of interventions that may alter the natural
history of joint arthritis from a tissue engineering or regenerative biologic
approach. In this workshop, we will highlight recent Canadian experience in
the evaluation of these strategies from a translational bench to clinic
research perspective. We will review our current clinical experience with
the use of mesenchymal stem cells (MSCs) for orthopaedic and joint arthritis
conditions. We will also present interesting observations on the stage-
specific behavior and secretory profile of MSCs exposed to early versus late-
stage osteoarthritis synovial fluid, when evaluated in co-culture laboratory
conditions. Finally, we will also highlight the importance of using a patient
specific approach in the development of tissue-engineered implants for
chondral resurfacing.i.org/10.1016/j.jot.2016.06.015SpeakersSpeaker 1: Development of patient-specific implants for
chondral resurfacing
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